E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Add to balance / Manage account  User:  Log out
Prospect News home > News index > List of issuers D > Headlines for Diocle SpA > News item
Published on 6/11/2019 in the Prospect News High Yield Daily.

Italy’s Doc Generici marketing €470 million senior secured notes

By Paul A. Harris

Portland, Ore., June 11 – Italian pharmaceutical group Doc Generici is in the market with a €470 million offering of senior secured notes (B2), sources say.

The issuing entity will be Diocle SpA.

UniCredit, BNP Paribas and Credit Agricole CIB are leading the sale.

The Milan-based generic drugmaker plans to use the proceeds to refinance debt incurred in the spring when Intermediate Capital Group and Merieux Equity Partners acquired Doc Generici from CVC Capital Partners for €1.1 billion.


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.